These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2571490)

  • 1. Oxidation of tenoxicam by leukocyte peroxidases and H2O2 produces novel products.
    Ichihara S; Tomisawa H; Fukazawa H; Tateishi M; Joly R; Heintz R
    Drug Metab Dispos; 1989; 17(4):463-8. PubMed ID: 2571490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of leukocyte peroxidases in the metabolism of tenoxicam.
    Ichihara S; Tomisawa H; Fukazawa H; Tateishi M
    Biochem Pharmacol; 1985 Apr; 34(8):1337-8. PubMed ID: 2986643
    [No Abstract]   [Full Text] [Related]  

  • 3. Analogues and derivatives of tenoxicam. 1. Synthesis and antiinflammatory activity of analogues with different residues on the ring nitrogen and the amide nitrogen.
    Binder D; Hromatka O; Geissler F; Schmied K; Noe CR; Burri K; Pfister R; Strub K; Zeller P
    J Med Chem; 1987 Apr; 30(4):678-82. PubMed ID: 3494124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of leukocytes in the oxygenation and chlorination reaction of phenylbutazone.
    Ichihara S; Tomisawa H; Fukazawa H; Tateishi M; Joly R; Heintz R
    Biochem Pharmacol; 1986 Nov; 35(22):3935-9. PubMed ID: 3778517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peroxidative metabolism of tenoxicam produces excited species.
    Nascimento AL; Escobar JA; Cilento G
    Photochem Photobiol; 1993 Feb; 57(2):362-6. PubMed ID: 8451298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolism of isoxicam by horseradish peroxidase.
    Woolf TF; Black A; Chang T
    Xenobiotica; 1989 Dec; 19(12):1369-77. PubMed ID: 2618088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zwitterionic nature of tenoxicam: crystal structures and thermal analyses of a polymorph of tenoxicam and a 1:1 tenoxicam:acetonitrile solvate.
    Caira MR; Nassimbeni LR; Timme M
    J Pharm Sci; 1995 Jul; 84(7):884-8. PubMed ID: 7562442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of novel dihydrothienopyridinium and thienopyridinium metabolites of ticlopidine in vitro: role of peroxidases, cytochromes p450, and monoamine oxidases.
    Dalvie DK; O'Connell TN
    Drug Metab Dispos; 2004 Jan; 32(1):49-57. PubMed ID: 14709620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of tenoxicam in human plasma by high-performance liquid chromatography.
    Heizmann P; Körner J; Zinapold K
    J Chromatogr; 1986 Jan; 374(1):95-102. PubMed ID: 3485110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The binding of oxicam derivatives to human serum albumin].
    Kinawi A; Siebler D
    Arzneimittelforschung; 1988 Aug; 38(8):1089-92. PubMed ID: 3264167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The elimination profiles of tenoxicam and hydroxytenoxicam in equine urine and serum after a 200-mg oral dose.
    Marland A; Sarkar P; Leavitt R
    J Anal Toxicol; 1999; 23(4):237-41. PubMed ID: 10445485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation of the indole nucleus of 5-hydroxytryptamine and formation of dimers in the presence of peroxidase and H2O2.
    Heuther G; Reimer A; Schmidt F; Schuff-Werner P; Brudny MM
    J Neural Transm Suppl; 1990; 32():249-57. PubMed ID: 2089095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the possible interaction between tenoxicam and furosemide.
    Hartmann D; Kleinbloesem CH; Lücker PW; Vetter G
    Arzneimittelforschung; 1987 Sep; 37(9):1072-6. PubMed ID: 3501723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release studies from smart hydrogels as carriers for piroxicam and copper(II)-oxicam complexes as anti-inflammatory and anti-cancer drugs. X-ray structures of new copper(II)-piroxicam and -isoxicam complex molecules.
    Tamasi G; Serinelli F; Consumi M; Magnani A; Casolaro M; Cini R
    J Inorg Biochem; 2008 Oct; 102(10):1862-73. PubMed ID: 18667239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
    Bird HA; Allen JG; Dixon JS; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo and in vitro investigation of the phototoxic potential of tenoxicam, a new non-steroidal anti-inflammatory agent.
    Anderson R; Eftychis HA; Weiner A; Findlay GH
    Dermatologica; 1987; 175(5):229-34. PubMed ID: 3678549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum albumin conformational changes as induced by tenoxicam and modified by simultaneous diazepam binding.
    Brée F; Urien S; Nguyen P; Tillement JP; Steiner A; Vallat-Molliet C; Testa B; Visy J; Simonyi M
    J Pharm Pharmacol; 1993 Dec; 45(12):1050-3. PubMed ID: 7908973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen peroxide utilization in myeloperoxidase-deficient leukocytes: a possible microbicidal control mechanism.
    Klebanoff SJ; Pincus SH
    J Clin Invest; 1971 Oct; 50(10):2226-9. PubMed ID: 5116211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil- and myeloperoxidase-mediated metabolism of reduced nimesulide: evidence for bioactivation.
    Yang M; Chordia MD; Li F; Huang T; Linden J; Macdonald TL
    Chem Res Toxicol; 2010 Nov; 23(11):1691-700. PubMed ID: 20939553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic analysis of piroxicam and tenoxicam in plasma, blood and buffer solution. Application to pharmacokinetic studies in small laboratory animals.
    Troconiz JI; Lopez-Bustamante LG; Fos D
    Arzneimittelforschung; 1993 Jun; 43(6):679-81. PubMed ID: 8352822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.